Abstract
In this paper, we present a brief overview of the methods which are commonly used for statistical analysis of data in competing risks settings. Moreover, we review 37 recent published clinical papers on breast cancer which consider an event of interest, such as breast cancer incident, while they also take into account the competing events, such as death due to other causes. The papers are selected based on the number of citations and publication year.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Pintilie, M.: Competing Risks: A Practical Perspective. Wiley, New York (2006)
Kalbfleisch, J.D., Prentice, R.L.: The Statistical Analysis of Failure Time Data, 1st edn. Wiley, New York (1980)
Putter, H., Ficco, M., Geskus, R.B.: Tutorial in biostatistics: competing risks and multi-state models. Stat. Med. 26(11), 2389–2430 (2007)
Fine, J.P., Gray, R.J.: A proportional hazards model for the subdistribution of a competing risk. J. Am. Stat. Assoc. 94(446), 496–509 (1999)
Pepe, M.S., Mori, M.: Kaplan-meier, marginal or conditional probability curves in summarizing competing risks failure time data? Stat. Med. 12(8), 737–751 (1993)
Travis, L.B., Hill, D., Dores, G.M., et al.: Cumulative absolute breast cancer risk for young women treated for Hodgkin lymphoma. J. Natl. Cancer Inst. 97, 1428–1437 (2005)
Degnim, A.C., Visscher, D.W., Berman, H.K., et al.: Stratification of breast cancer risk in women with atypia: a Mayo cohort study. J. Clin. Oncol. 25, 2671–2677 (2007)
Hwang, E.S., McLennan, J.L., Moore, D.H., et al.: Ductal carcinoma in situ in BRCA mutation carriers. J. Clin. Oncol. 25(6), 642–647 (2007)
Kerlikowske, K., Molinaro, A.M., Gauthier, M.L., et al.: Biomarker expression and risk of subsequent tumors after initial ductal carcinoma in situ diagnosis. J. Natl. Cancer Inst. 102, 627–637 (2010)
Kurian, A.W., Fish, K., Shema, S., et al.: Lifetime risks of specific breast cancer subtypes among women in four racial/ethnic groups. Breast Cancer Res. 12(6), R99 (2010)
Yi, M., Hunt, K.K., Arun, B.K., et al.: Factors affecting the decision of breast cancer patients to undergo contralateral prophylactic mastectomy. Cancer Prev. Res. 3(8), 1026–1034 (2010)
Biggar, R.J., Wohlfahrt, J., Oudin, A., et al.: Digoxin use and the risk of breast cancer in women. J. Clin. Oncol. 29(16), 2165–2170 (2011)
Luo, J., Horn, K., Ockene, J.K., et al.: Interaction between smoking and obesity and the risk of developing breast cancer among postmenopausal women: the Women’s Health Initiative Observational Study. Am. J. Epidemiol. 174(8), 919–928 (2011)
Petracci, E., Decarli, A., Schairer, C., et al.: Risk factor modification and projections of absolute breast cancer risk. J. Natl. Cancer Inst. 103(13), 1037–1048 (2011)
Warner, E., Hill, K., Causer, P., et al.: Prospective study of breast cancer incidence in women with a BRCA1 or BRCA2 mutation under surveillance with and without magnetic resonance imaging. J. Clin. Oncol. 29, 1664–1669 (2011)
Taghipour, S., Banjevic, D., Fernandes, J., et al.: Incidence of invasive breast cancer in the presence of competing mortality: The Canadian National Breast Screening Study. Breast Cancer Res. Treat. 134(2), 839–851 (2012)
Schairer, C., Mink, P.J., Carroll, L., et al.: Probabilities of death from breast cancer and other causes among female breast cancer patients. J. Natl. Cancer Inst. 96(17), 1311–1321 (2004)
Dalton, S.O., Ross, L., During, M., et al.: Influence of socioeconomic factors on survival after breast cancer – a nationwide cohort study of women diagnosed with breast cancer in Denmark 1983–1999. Int. J. Cancer 121, 2524–2531 (2007)
Hanrahan, E.O., Gonzalez-Angulo, A.M., Giordano, S.H., et al.: Overall survival and cause-specific mortality of patients with stage T1a, bN0M0 breast carcinoma. J. Clin. Oncol. 25, 4952–4960 (2007)
Chapman, J.A., Meng, D., Shepherd, L., et al.: Competing causes of death from a randomized trial of extended adjuvant endocrine therapy for breast cancer. J. Natl. Cancer Inst. 100(4), 252–260 (2008)
Newcomb, P.A., Egan, K.M., Trentham-Dietz, A., et al.: Prediagnostic use of hormone therapy and mortality after breast cancer. Cancer Epidemiol. Biomarkers Prev. 7(4), 864–871 (2008)
Kalinsky, K., Jacks, L.M., Heguy, A., et al.: PIK3CA mutation associates with improved outcome in breast cancer. Clin. Cancer Res. 15(16), 5049–5059 (2009)
Komenaka, I.K., Martinez, M.E., Pennington Jr., R.E., et al.: Race and ethnicity and breast cancer outcomes in an underinsured population. J. Natl. Cancer Inst. 102(15), 1178–1187 (2010)
Vinh-Hung, V., Joseph, S.A., Coutty, N., et al.: Age and axillary lymph node ratio in postmenopausal women with T1-T2 node positive breast cancer. Oncologist 15, 1050–1062 (2010)
Fisher, B., Bryant, J., Dignam, J.J., et al.: Tamoxifen, radiation therapy, or both for prevention of ipsilateral breast tumor recurrence after lumpectomy in women with invasive breast cancers of one centimeter or less. J. Clin. Oncol. 20(20), 4141–4149 (2002)
Dignam, J.J., Wieand, K., Johnson, K.A., et al.: Effects of obesity and race on prognosis in lymph node-negative, estrogen receptor-negative breast cancer. Breast Cancer Res. Treat. 97, 245–254 (2006)
Nottage, M.K., Kopciuk, K.A., Tzontcheva, A., et al.: Analysis of incidence and prognostic factors for ipsilateral breast tumour recurrence and its impact on disease-specific survival of women with nodenegative breast cancer: a prospective cohort study. Breast Cancer Res. 8, R44 (2006)
Nguyen, P.L., Taghian, A.G., Katz, M.S., et al.: Breast cancer subtype approximated by estrogen receptor, progesterone receptor, and HER-2 is associated with local and distant recurrence after breast-conserving therapy. J. Clin. Oncol. 26(14), 2373–2378 (2008)
Schaapveld, M., Visser, O., Louwman, W.J., et al.: The impact of adjuvant therapy on contralateral breast cancer risk and the prognostic significance of contralateral breast cancer: a population based study in the Netherlands. Breast Cancer Res. Treat. 110, 189–197 (2008)
Yerushalmi, R., Kennecke, H., Woods, R., Olivotto, I.A., Speers, C., Gelmon, K.A.: Does multicentric/multifocal breast cancer differ from unifocal breast cancer? An analysis of survival and contralateral breast cancer incidence. Breast Cancer Res. Treat. 117(2), 365–370 (2009)
Mell, L.K., Jeong, J., Nichols, M.A., et al.: Predictors of competing mortality in early breast cancer. Cancer 116(23), 5365–5373 (2010)
Galimberti, V., Botteri, E., Chifu, C., et al.: Can we avoid axillary dissection in the micrometastatic sentinel node in breast cancer? Breast Cancer Res. Treat. 131, 819–825 (2012)
Nsouli-Maktabi, H., Henson, D., Younes, N., Young, H., Cleary, S.: Second primary breast, endometrial, and ovarian cancers in Black and White breast cancer survivors over a 35-year time span: effect of age. Breast Cancer Res. Treat. 129(3), 963–969 (2011)
Crump, M., Tu, D., Sheperd, L., et al.: Risk of acute leukemia following epirubicin-based adjuvant chemotherapy: a report from the National Cancer Institute of Canada Clinical Trials Group. J. Clin. Oncol. 21(16), 3066–3071 (2003)
Ryberg, M., Nielsen, D., Osterlind, K., et al.: Predictors of central nervous system metastasis in patients with metastatic breast cancer. A competing risk analysis of 579 patients treated with epirubicin-based chemotherapy. Breast Cancer Res. Treat. 91, 217–225 (2005)
Pestalozzi, B.C., Zahrieh, D., Price, K.N., et al.: Identifying breast cancer patients at risk for central nervous system (CNS) metastases in trials of the International Breast Cancer Study Group (IBCSG). Ann. Oncol. 17, 935–944 (2006)
Brown, L.M., Chen, B.E., Pfeiffer, R.M., et al.: Risk of second non-hematological malignancies among 376,825 breast cancer survivors. Breast Cancer Res. Treat. 106, 439–451 (2007)
Howard, R.A., Gilbert, E.S., Chen, B.E., et al.: Leukemia following breast cancer: an international population-based study of 376,825 women. Breast Cancer Res. Treat. 105, 359–368 (2007)
Marees, T., Moll, A.C., Imhof, S.M., et al.: Risk of second malignancies in survivors of retinoblastoma: more than 40 years of follow-up. J. Natl. Cancer Inst. 100(24), 1771–1779 (2008)
Ryberg, M., Nielsen, D., Cortese, G., et al.: New insight into epirubicin cardiac toxicity: competing risks analysis of 1097 breast cancer patients. J. Natl. Cancer Inst. 100(15), 1058–1067 (2008)
Schaapveld, M., Visser, O., Louwman, M.J., et al.: Risk of new primary nonbreast cancers after breast cancer treatment: a Dutch population-based study. J. Clin. Oncol. 26(8), 1239–1246 (2008)
Kennecke, H., Yerushalmi, R., Woods, R., et al.: Metastatic behavior of breast cancer subtypes. J. Clin. Oncol. 28(20), 3271–3277 (2010)
Scrucca, L., Santucci, A., Aversa, F.: Regression modeling of competing risk using R: an in depth guide for clinicians. Bone Marrow Transplant. 45, 1388–1395 (2010)
Gail, M.H.: Estimation and interpretation of models of absolute risk from epidemiologic data, including family-based studies. Lifetime Data Anal. 14, 18–36 (2008)
Gail, M.H.: Personalized estimates of breast cancer risk in clinical practice and public health. Stat. Med. 30(10), 1090–1104 (2011)
Koller, M.T., Raatz, H., Steyerberg, E.W., et al.: Competing risks in the clinical community: irrelevance or ignorance? Stat. Med. 31, 1089–1097 (2012)
Acknowledgements
We acknowledge the Natural Sciences and Engineering Research Council of Canada and the Canadian Institutes of Health Research for their financial support.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer Science+Business Media New York
About this paper
Cite this paper
Taghipour, S., Banjevic, D., Miller, A., Harvey, B. (2013). Competing Risks Models and Breast Cancer: A Brief Review. In: Lee, ML., Gail, M., Pfeiffer, R., Satten, G., Cai, T., Gandy, A. (eds) Risk Assessment and Evaluation of Predictions. Lecture Notes in Statistics, vol 215. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-8981-8_14
Download citation
DOI: https://doi.org/10.1007/978-1-4614-8981-8_14
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4614-8980-1
Online ISBN: 978-1-4614-8981-8
eBook Packages: Mathematics and StatisticsMathematics and Statistics (R0)